Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares MSCI Europe Mid Cap UCITS ETF

EUMD · IE00BF20LF40 · EUR · domicile Ireland
Equity · Europe · Mid capSFDR art. 6
Index tracked: MSCI Europe Mid Cap - NR (EUR) Index
TER
0.15%+ trans. 0.04%
Fund size
581 m EUR
Tracking difference
+0.26%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (optimised)
Income
Accumulating
Launch 22 May 2017 · costs from the KID as of 2 Sept 2026 · 213 securities held · 6 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the MSCI Europe Mid Cap Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The Index measures the performance of mid-capitalisation companies across developed market countries in Europe which comply with…

Performance since series start (in euro) — base 100

18 May 201731 Aug 2026 · dividends reinvested where declared by the issuer
2018202020222024202621379212
High 213 (25 Aug 2026) · low 79 (17 Mar 2020) · last 212. Past performance is not indicative of future results.

Returns in euro

1 year+20.9%
3 years+61.7%
5 years+44.8%
10 yearsseries too young
Since series start+111.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)10.98%12.32%14.97%
Max drawdown−8.38%−13.97%−29.26%
Sharpe1.541.120.41
Sortino2.281.580.56
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EUMD · IE00BF20LF401
RebalixEUMD · IE00BF20LF40 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+23.17%+22.78%+0.39%
2024+9.42%+9.25%+0.17%
2023+14.41%+14.19%+0.23%
2022−18.93%−19.27%+0.34%
2021+21.70%+21.60%+0.10%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 213 securities · top-10 weight = 12.6%
Top holdingsWeight
PRYSMIAN1.6%
SANDOZ GROUP AG1.4%
REPSOL1.4%
VESTAS WIND SYSTEMS1.3%
SWISS LIFE HOLDING AG1.3%
ABN AMRO BANK NV1.2%
AVIVA PLC1.2%
PUBLICIS GROUPE1.1%
AIB GROUP PLC1.1%
LEONARDO FINMECCANICA SPA1.0%
Countries (% of fund)
United Kingdom17.3%Switzerland10.8%Italy10.2%France9.8%Sweden9.6%
Sectors (% of fund)
Industrials25.7%Financials22.8%Health Care8.7%Consumer Staples7.2%Consumer Discretionary6.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
2B72 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/eumd-ishares-msci-e
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE00BF20LF40
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EUMD · IE00BF20LF402